These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27732936)

  • 1. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.
    Albino D; Civenni G; Rossi S; Mitra A; Catapano CV; Carbone GM
    Oncotarget; 2016 Nov; 7(47):76756-76768. PubMed ID: 27732936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features.
    Albino D; Longoni N; Curti L; Mello-Grand M; Pinton S; Civenni G; Thalmann G; D'Ambrosio G; Sarti M; Sessa F; Chiorino G; Catapano CV; Carbone GM
    Cancer Res; 2012 Jun; 72(11):2889-900. PubMed ID: 22505649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer.
    Albino D; Civenni G; Dallavalle C; Roos M; Jahns H; Curti L; Rossi S; Pinton S; D'Ambrosio G; Sessa F; Hall J; Catapano CV; Carbone GM
    Cancer Res; 2016 Jun; 76(12):3629-43. PubMed ID: 27197175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.
    Dallavalle C; Albino D; Civenni G; Merulla J; Ostano P; Mello-Grand M; Rossi S; Losa M; D'Ambrosio G; Sessa F; Thalmann GN; Garcia-Escudero R; Zitella A; Chiorino G; Catapano CV; Carbone GM
    J Clin Invest; 2016 Dec; 126(12):4585-4602. PubMed ID: 27820701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression.
    Longoni N; Kunderfranco P; Pellini S; Albino D; Mello-Grand M; Pinton S; D'Ambrosio G; Sarti M; Sessa F; Chiorino G; Catapano CV; Carbone GM
    Oncogene; 2013 May; 32(18):2315-24, 2324.e1-4. PubMed ID: 22733135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
    Mathews LA; Hurt EM; Zhang X; Farrar WL
    Mol Cancer; 2010 Oct; 9():267. PubMed ID: 20929579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB.
    Civenni G; Longoni N; Costales P; Dallavalle C; García Inclán C; Albino D; Nuñez LE; Morís F; Carbone GM; Catapano CV
    Mol Cancer Ther; 2016 May; 15(5):806-18. PubMed ID: 26826115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract.
    Liu Y; Luo F; Xu Y; Wang B; Zhao Y; Xu W; Shi L; Lu X; Liu Q
    Toxicol Appl Pharmacol; 2015 Jan; 282(1):9-19. PubMed ID: 25447409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer.
    Yu W; Srivastava R; Srivastava S; Ma Y; Shankar S; Srivastava RK
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation.
    Gu L; Talati P; Vogiatzi P; Romero-Weaver AL; Abdulghani J; Liao Z; Leiby B; Hoang DT; Mirtti T; Alanen K; Zinda M; Huszar D; Nevalainen MT
    Mol Cancer Ther; 2014 May; 13(5):1246-58. PubMed ID: 24577942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer.
    Xiong X; Schober M; Tassone E; Khodadadi-Jamayran A; Sastre-Perona A; Zhou H; Tsirigos A; Shen S; Chang M; Melamed J; Ossowski L; Wilson EL
    Cell Rep; 2018 Dec; 25(11):3006-3020.e7. PubMed ID: 30540935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
    Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
    Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
    Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
    J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
    Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
    Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
    Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
    PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
    Sun B; Han Y; Cai H; Huang H; Xuan Y
    Cell Oncol (Dordr); 2021 Feb; 44(1):179-192. PubMed ID: 32930970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
    Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.